Literature DB >> 28867742

Effect of Infectious Diseases on the Pathogenesis of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis.

Yoshimi Okamoto-Uchida1, Ryosuke Nakamura1, Kimie Sai1, Takuya Imatoh1, Kayoko Matsunaga2, Michiko Aihara3, Yoshiro Saito1.   

Abstract

Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) are severe cutaneous adverse drug reactions. Recent studies have revealed that the prevalence of SJS/TEN is associated with genetic backgrounds, such as polymorphisms in human leukocyte antigens (HLAs). However, non-genetic factors contributing to the etiology of SJS/TEN are largely unknown. This study aimed to assess the involvement of concurrent infection on the pathological states of SJS/TEN, examining the severity of cutaneous symptoms and ocular involvement as well as the time to onset in drug-induced SJS/TEN patients. We recruited 257 Japanese SJS/TEN patients from June 2006 to September 2013 through a nationwide case collection network and participating hospitals and reviewed the clinical information including patient backgrounds, primary disease and medication status. Association between infection and pathological states of SJS/TEN was assessed using univariate and multivariate analyses. The concurrent infectious group of SJS/TEN patients showed a significantly higher rate of exhibiting severer dermatological and ophthalmological phenotypes and an earlier onset of SJS/TEN than the non-infectious group. Our results suggest that the infection could be a risk factor to cause severer symptoms and earlier onset of SJS/TEN.

Entities:  

Keywords:  Stevens–Johnson syndrome; epidemiological study; heterologous immunity; infection; toxic epidermal necrolysis

Mesh:

Year:  2017        PMID: 28867742     DOI: 10.1248/bpb.b17-00207

Source DB:  PubMed          Journal:  Biol Pharm Bull        ISSN: 0918-6158            Impact factor:   2.233


  6 in total

Review 1.  Severe Cutaneous Adverse Drug Reactions: Presentation, Risk Factors, and Management.

Authors:  S Shahzad Mustafa; David Ostrov; Daniel Yerly
Journal:  Curr Allergy Asthma Rep       Date:  2018-03-24       Impact factor: 4.806

2.  Epidemiology of Severe Cutaneous Adverse Drug Reaction and Its HLA Association among Pediatrics.

Authors:  Hossein Esmaeilzadeh; Shirin Farjadian; Soheila Alyasin; Hamid Nemati; Hesamodin Nabavizadeh; Elmira Esmaeilzadeh
Journal:  Iran J Pharm Res       Date:  2019       Impact factor: 1.696

3.  Severe Cutaneous Adverse Reactions: A Single-Center Retrospective Study of 173 Patients in China.

Authors:  Zhongyi Xu; Jie Shen; Yiwen Yang; Ruoyue Yuan; Leihong Flora Xiang; Chengfeng Zhang
Journal:  Ann Dermatol       Date:  2019-08-30       Impact factor: 1.444

4.  Increased Predisposition of SJS TEN in COVID-19 Patients, Presenting as Post COVID Complication: Report of Two Cases.

Authors:  Shayna Aulakh; Raina Arora; Rishu Sarangal; Dimple Chopra
Journal:  Indian Dermatol Online J       Date:  2022-03-03

Review 5.  Lamotrigine and Stevens-Johnson Syndrome Prevention.

Authors:  Amber N Edinoff; Long H Nguyen; Mary Jo Fitz-Gerald; Erin Crane; Kyle Lewis; Samantha St Pierre; Alan D Kaye; Adam M Kaye; Jessica S Kaye; Rachel J Kaye; Sonja A Gennuso; Giustino Varrassi; Omar Viswanath; Ivan Urits
Journal:  Psychopharmacol Bull       Date:  2021-03-16

Review 6.  Current Perspectives on Severe Drug Eruption.

Authors:  Jingzhan Zhang; Zixian Lei; Chen Xu; Juan Zhao; Xiaojing Kang
Journal:  Clin Rev Allergy Immunol       Date:  2021-07-17       Impact factor: 8.667

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.